[Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies].
D000017:ABO Blood-Group System; D001787:Blood Group Incompatibility / Q000517:prevention & control; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005331:Fetomaternal Transfusion; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007136:Immunoglobulins / Q000627:therapeutic use*; D007226:Infant Mortality; D007231:Infant, Newborn; D011247:Pregnancy
D000017:ABO Blood-Group System; D007074:Immunoglobulin G; D007136:Immunoglobulins
Die Prophylaxe der Rhesus-Sensibilisierung mit Anti-D, zehn Jahre nach Beginn der ersten Untersuchungen.